Selected research
Industry Research
Plasma and Serum Proteomics Analysis Service Industry Research Report 2026
Market perspective
The global Plasma and Serum Proteomics Analysis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasma and Serum Proteomics Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasma and Serum Proteomics Analysis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasma and Serum Proteomics Analysis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasma and Serum Proteomics Analysis Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasma and Serum Proteomics Analysis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasma and Serum Proteomics Analysis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma and Serum Proteomics Analysis Service Market by Company
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
Plasma and Serum Proteomics Analysis Service Segment by Type
Plasma Proteomics Analysis Service
Serum Proteomics Analysis Service
Plasma and Serum Proteomics Analysis Service Segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Plasma and Serum Proteomics Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma and Serum Proteomics Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma and Serum Proteomics Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma and Serum Proteomics Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma and Serum Proteomics Analysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2021-2026)
Table 7. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2027-2032)
Table 9. Global Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021-2026)
Table 11. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2027-2032)
Table 13. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2021-2026)
Table 16. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2027-2032)
Table 18. Plasma and Serum Proteomics Analysis Service Industry Trends
Table 19. Plasma and Serum Proteomics Analysis Service Industry Drivers
Table 20. Plasma and Serum Proteomics Analysis Service Industry Opportunities and Challenges
Table 21. Plasma and Serum Proteomics Analysis Service Market Restraints
Table 22. Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Players (2021-2026)
Table 24. Global Plasma and Serum Proteomics Analysis Service Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Plasma and Serum Proteomics Analysis Service, Headquarters and Area Served
Table 26. Global Plasma and Serum Proteomics Analysis Service Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Plasma and Serum Proteomics Analysis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032) & (US$ Million)
Table 45. BostonGene Company Information
Table 46. BostonGene Business Overview
Table 47. BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 48. BostonGene Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 49. BostonGene Recent Developments
Table 50. CellCarta Company Information
Table 51. CellCarta Business Overview
Table 52. CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 53. CellCarta Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 54. CellCarta Recent Developments
Table 55. GENEWIZ (Azenta Life Sciences) Company Information
Table 56. GENEWIZ (Azenta Life Sciences) Business Overview
Table 57. GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 58. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 59. GENEWIZ (Azenta Life Sciences) Recent Developments
Table 60. CDI Labs Company Information
Table 61. CDI Labs Business Overview
Table 62. CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 63. CDI Labs Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 64. CDI Labs Recent Developments
Table 65. Biognosys Company Information
Table 66. Biognosys Business Overview
Table 67. Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 68. Biognosys Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 69. Biognosys Recent Developments
Table 70. Discovery Life Sciences Company Information
Table 71. Discovery Life Sciences Business Overview
Table 72. Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 73. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 74. Discovery Life Sciences Recent Developments
Table 75. Firalis Molecular Precision Company Information
Table 76. Firalis Molecular Precision Business Overview
Table 77. Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 78. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 79. Firalis Molecular Precision Recent Developments
Table 80. Cell Signaling Technology (CST) Company Information
Table 81. Cell Signaling Technology (CST) Business Overview
Table 82. Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 83. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 84. Cell Signaling Technology (CST) Recent Developments
Table 85. Sampled (Infinity Biologix) Company Information
Table 86. Sampled (Infinity Biologix) Business Overview
Table 87. Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 88. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 89. Sampled (Infinity Biologix) Recent Developments
Table 90. APTBIO Company Information
Table 91. APTBIO Business Overview
Table 92. APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 93. APTBIO Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 94. APTBIO Recent Developments
Table 95. Sinotech Genomics Company Information
Table 96. Sinotech Genomics Business Overview
Table 97. Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 98. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 99. Sinotech Genomics Recent Developments
Table 100. Biodesix Company Information
Table 101. Biodesix Business Overview
Table 102. Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 103. Biodesix Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 104. Biodesix Recent Developments
Table 105. Panome Bio Company Information
Table 106. Panome Bio Business Overview
Table 107. Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 108. Panome Bio Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 109. Panome Bio Recent Developments
Table 110. Novogene Company Information
Table 111. Novogene Business Overview
Table 112. Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 113. Novogene Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 114. Novogene Recent Developments
Table 115. PTM BIO Company Information
Table 116. PTM BIO Business Overview
Table 117. PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 118. PTM BIO Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 119. PTM BIO Recent Developments
Table 120. BGI Genomics Company Information
Table 121. BGI Genomics Business Overview
Table 122. BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 123. BGI Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 124. BGI Genomics Recent Developments
Table 125. Evotec Company Information
Table 126. Evotec Business Overview
Table 127. Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 128. Evotec Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 129. Evotec Recent Developments
Table 130. Metware Biotechnology Company Information
Table 131. Metware Biotechnology Business Overview
Table 132. Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 133. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 134. Metware Biotechnology Recent Developments
Table 135. MRM Proteomics Company Information
Table 136. MRM Proteomics Business Overview
Table 137. MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 138. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 139. MRM Proteomics Recent Developments
Table 140. Lc-Bio Technologies Company Information
Table 141. Lc-Bio Technologies Business Overview
Table 142. Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 143. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 144. Lc-Bio Technologies Recent Developments
Table 145. Eurofins Scientific Company Information
Table 146. Eurofins Scientific Business Overview
Table 147. Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 148. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 149. Eurofins Scientific Recent Developments
Table 150. MtoZ-Biolabs Company Information
Table 151. MtoZ-Biolabs Business Overview
Table 152. MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 153. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 154. MtoZ-Biolabs Recent Developments
Table 155. Creative Proteomics Company Information
Table 156. Creative Proteomics Business Overview
Table 157. Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 158. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 159. Creative Proteomics Recent Developments
Table 160. Macrogen Company Information
Table 161. Macrogen Business Overview
Table 162. Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 163. Macrogen Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 164. Macrogen Recent Developments
Table 165. TATAA Biocenter Company Information
Table 166. TATAA Biocenter Business Overview
Table 167. TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 168. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 169. TATAA Biocenter Recent Developments
Table 170. OmicScouts (Momentum Biotechnologies) Company Information
Table 171. OmicScouts (Momentum Biotechnologies) Business Overview
Table 172. OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 173. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 174. OmicScouts (Momentum Biotechnologies) Recent Developments
Table 175. Precision Biomarker Laboratories (PBL) Company Information
Table 176. Precision Biomarker Laboratories (PBL) Business Overview
Table 177. Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 178. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 179. Precision Biomarker Laboratories (PBL) Recent Developments
Table 180. Shanghai OE Biotech Company Information
Table 181. Shanghai OE Biotech Business Overview
Table 182. Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 183. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 184. Shanghai OE Biotech Recent Developments
Table 185. RxCelerate Company Information
Table 186. RxCelerate Business Overview
Table 187. RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 188. RxCelerate Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 189. RxCelerate Recent Developments
Table 190. Proteomics International Company Information
Table 191. Proteomics International Business Overview
Table 192. Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 193. Proteomics International Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 194. Proteomics International Recent Developments
Table 195. Proteome Sciences Company Information
Table 196. Proteome Sciences Business Overview
Table 197. Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 198. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 199. Proteome Sciences Recent Developments
Table 200. Westlake Omics Company Information
Table 201. Westlake Omics Business Overview
Table 202. Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 203. Westlake Omics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 204. Westlake Omics Recent Developments
Table 205. Crown Bioscience Company Information
Table 206. Crown Bioscience Business Overview
Table 207. Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 208. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 209. Crown Bioscience Recent Developments
Table 210. VProteomics Company Information
Table 211. VProteomics Business Overview
Table 212. VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 213. VProteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 214. VProteomics Recent Developments
Table 215. Shanghai Majorbio Bio-Pharm Company Information
Table 216. Shanghai Majorbio Bio-Pharm Business Overview
Table 217. Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 218. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 219. Shanghai Majorbio Bio-Pharm Recent Developments
Table 220. Applied Biomics Company Information
Table 221. Applied Biomics Business Overview
Table 222. Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 223. Applied Biomics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 224. Applied Biomics Recent Developments
Table 225. Sapient Bioanalytics Company Information
Table 226. Sapient Bioanalytics Business Overview
Table 227. Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 228. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 229. Sapient Bioanalytics Recent Developments
Table 230. Allumiqs Company Information
Table 231. Allumiqs Business Overview
Table 232. Allumiqs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 233. Allumiqs Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 234. Allumiqs Recent Developments
Table 235. MS Bioworks Company Information
Table 236. MS Bioworks Business Overview
Table 237. MS Bioworks Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 238. MS Bioworks Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 239. MS Bioworks Recent Developments
Table 240. Shanghai Bioprofile Company Information
Table 241. Shanghai Bioprofile Business Overview
Table 242. Shanghai Bioprofile Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 243. Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 244. Shanghai Bioprofile Recent Developments
Table 245. Cosmos Wisdom Company Information
Table 246. Cosmos Wisdom Business Overview
Table 247. Cosmos Wisdom Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 248. Cosmos Wisdom Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 249. Cosmos Wisdom Recent Developments
Table 250. Olink (Thermo Fisher Scientific) Company Information
Table 251. Olink (Thermo Fisher Scientific) Business Overview
Table 252. Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 253. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 254. Olink (Thermo Fisher Scientific) Recent Developments
Table 255. SomaLogic (Illumina) Company Information
Table 256. SomaLogic (Illumina) Business Overview
Table 257. SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 258. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 259. SomaLogic (Illumina) Recent Developments
Table 260. Labcorp Company Information
Table 261. Labcorp Business Overview
Table 262. Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)
Table 263. Labcorp Plasma and Serum Proteomics Analysis Service Product Portfolio
Table 264. Labcorp Recent Developments
Table 265. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Plasma and Serum Proteomics Analysis Service Product Image
Figure 5. Global Plasma and Serum Proteomics Analysis Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Plasma and Serum Proteomics Analysis Service Market Share by Type: 2025 VS 2032
Figure 7. Plasma Proteomics Analysis Service Product
Figure 8. Serum Proteomics Analysis Service Product
Figure 9. Global Plasma and Serum Proteomics Analysis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Plasma and Serum Proteomics Analysis Service Market Share by Application: 2025 VS 2032
Figure 11. Disease Biomarker Research Product
Figure 12. Drug Development Product
Figure 13. Clinical Research Product
Figure 14. Others Product
Figure 15. Global Plasma and Serum Proteomics Analysis Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Plasma and Serum Proteomics Analysis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Plasma and Serum Proteomics Analysis Service Market Share by Region: 2025 VS 2032
Figure 18. Global Plasma and Serum Proteomics Analysis Service Market Share by Players in 2025
Figure 19. Global Plasma and Serum Proteomics Analysis Service Manufacturers Established Date
Figure 20. Global Top 5 and 10 Plasma and Serum Proteomics Analysis Service Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 24. United States Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 27. Europe Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 29. Germany Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 39. China Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 44. Australia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Plasma and Serum Proteomics Analysis Service Market Share by Country (2021-2032)
Figure 49. Brazil Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru Plasma and Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. BostonGene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 55. CellCarta Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 56. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 57. CDI Labs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 58. Biognosys Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 59. Discovery Life Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 60. Firalis Molecular Precision Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 61. Cell Signaling Technology (CST) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 62. Sampled (Infinity Biologix) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 63. APTBIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 64. Sinotech Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 65. Biodesix Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 66. Panome Bio Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 67. Novogene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 68. PTM BIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 69. BGI Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 70. Evotec Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 71. Metware Biotechnology Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 72. MRM Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 73. Lc-Bio Technologies Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 74. Eurofins Scientific Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 75. MtoZ-Biolabs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 76. Creative Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 77. Macrogen Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 78. TATAA Biocenter Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 79. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 80. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 81. Shanghai OE Biotech Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 82. RxCelerate Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 83. Proteomics International Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 84. Proteome Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 85. Westlake Omics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 86. Crown Bioscience Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 87. VProteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 88. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 89. Applied Biomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 90. Sapient Bioanalytics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 91. Allumiqs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 92. MS Bioworks Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 93. Shanghai Bioprofile Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 94. Cosmos Wisdom Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 95. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 96. SomaLogic (Illumina) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Figure 97. Labcorp Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
Scope & coverage.
Types
- Plasma Proteomics Analysis Service
- Serum Proteomics Analysis Service
Applications
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
Companies covered
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma and Serum Proteomics Analysis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plasma Proteomics Analysis Service
- 2.2.3 Serum Proteomics Analysis Service
- 2.3 Plasma and Serum Proteomics Analysis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Biomarker Research
- 2.3.3 Drug Development
- 2.3.4 Clinical Research
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Plasma and Serum Proteomics Analysis Service Breakdown Data by Type
- 3.1 Global Plasma and Serum Proteomics Analysis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (2027-2032)
4 Plasma and Serum Proteomics Analysis Service Breakdown Data by Application
- 4.1 Global Plasma and Serum Proteomics Analysis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasma and Serum Proteomics Analysis Service Market Perspective (2021-2032)
- 5.2 Global Plasma and Serum Proteomics Analysis Service Growth Trends by Region
- 5.2.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasma and Serum Proteomics Analysis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Plasma and Serum Proteomics Analysis Service Market Dynamics
- 5.3.1 Plasma and Serum Proteomics Analysis Service Industry Trends
- 5.3.2 Plasma and Serum Proteomics Analysis Service Market Drivers
- 5.3.3 Plasma and Serum Proteomics Analysis Service Market Challenges
- 5.3.4 Plasma and Serum Proteomics Analysis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue
- 6.1.1 Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue (2021-2026)
- 6.1.2 Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasma and Serum Proteomics Analysis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma and Serum Proteomics Analysis Service Head Office and Area Served
- 6.4 Global Plasma and Serum Proteomics Analysis Service Players, Product Type & Application
- 6.5 Global Plasma and Serum Proteomics Analysis Service Manufacturers Established Date
- 6.6 Global Plasma and Serum Proteomics Analysis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasma and Serum Proteomics Analysis Service Market Size (2021-2032)
- 7.2 North America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026)
- 7.4 North America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasma and Serum Proteomics Analysis Service Market Size (2021-2032)
- 8.2 Europe Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026)
- 8.4 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasma and Serum Proteomics Analysis Service Market Size (2021-2032)
- 10.2 South America Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026)
- 10.4 South America Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BostonGene
- 12.1.1 BostonGene Company Information
- 12.1.2 BostonGene Business Overview
- 12.1.3 BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.1.4 BostonGene Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.1.5 BostonGene Recent Developments
- 12.2 CellCarta
- 12.2.1 CellCarta Company Information
- 12.2.2 CellCarta Business Overview
- 12.2.3 CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.2.4 CellCarta Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.2.5 CellCarta Recent Developments
- 12.3 GENEWIZ (Azenta Life Sciences)
- 12.3.1 GENEWIZ (Azenta Life Sciences) Company Information
- 12.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 12.3.3 GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.3.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 12.4 CDI Labs
- 12.4.1 CDI Labs Company Information
- 12.4.2 CDI Labs Business Overview
- 12.4.3 CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.4.4 CDI Labs Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.4.5 CDI Labs Recent Developments
- 12.5 Biognosys
- 12.5.1 Biognosys Company Information
- 12.5.2 Biognosys Business Overview
- 12.5.3 Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.5.4 Biognosys Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.5.5 Biognosys Recent Developments
- 12.6 Discovery Life Sciences
- 12.6.1 Discovery Life Sciences Company Information
- 12.6.2 Discovery Life Sciences Business Overview
- 12.6.3 Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.6.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.6.5 Discovery Life Sciences Recent Developments
- 12.7 Firalis Molecular Precision
- 12.7.1 Firalis Molecular Precision Company Information
- 12.7.2 Firalis Molecular Precision Business Overview
- 12.7.3 Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.7.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.7.5 Firalis Molecular Precision Recent Developments
- 12.8 Cell Signaling Technology (CST)
- 12.8.1 Cell Signaling Technology (CST) Company Information
- 12.8.2 Cell Signaling Technology (CST) Business Overview
- 12.8.3 Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.8.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.8.5 Cell Signaling Technology (CST) Recent Developments
- 12.9 Sampled (Infinity Biologix)
- 12.9.1 Sampled (Infinity Biologix) Company Information
- 12.9.2 Sampled (Infinity Biologix) Business Overview
- 12.9.3 Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.9.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.9.5 Sampled (Infinity Biologix) Recent Developments
- 12.10 APTBIO
- 12.10.1 APTBIO Company Information
- 12.10.2 APTBIO Business Overview
- 12.10.3 APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.10.4 APTBIO Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.10.5 APTBIO Recent Developments
- 12.11 Sinotech Genomics
- 12.11.1 Sinotech Genomics Company Information
- 12.11.2 Sinotech Genomics Business Overview
- 12.11.3 Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.11.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.11.5 Sinotech Genomics Recent Developments
- 12.12 Biodesix
- 12.12.1 Biodesix Company Information
- 12.12.2 Biodesix Business Overview
- 12.12.3 Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.12.4 Biodesix Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.12.5 Biodesix Recent Developments
- 12.13 Panome Bio
- 12.13.1 Panome Bio Company Information
- 12.13.2 Panome Bio Business Overview
- 12.13.3 Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.13.4 Panome Bio Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.13.5 Panome Bio Recent Developments
- 12.14 Novogene
- 12.14.1 Novogene Company Information
- 12.14.2 Novogene Business Overview
- 12.14.3 Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.14.4 Novogene Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.14.5 Novogene Recent Developments
- 12.15 PTM BIO
- 12.15.1 PTM BIO Company Information
- 12.15.2 PTM BIO Business Overview
- 12.15.3 PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.15.4 PTM BIO Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.15.5 PTM BIO Recent Developments
- 12.16 BGI Genomics
- 12.16.1 BGI Genomics Company Information
- 12.16.2 BGI Genomics Business Overview
- 12.16.3 BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.16.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.16.5 BGI Genomics Recent Developments
- 12.17 Evotec
- 12.17.1 Evotec Company Information
- 12.17.2 Evotec Business Overview
- 12.17.3 Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.17.4 Evotec Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.17.5 Evotec Recent Developments
- 12.18 Metware Biotechnology
- 12.18.1 Metware Biotechnology Company Information
- 12.18.2 Metware Biotechnology Business Overview
- 12.18.3 Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.18.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.18.5 Metware Biotechnology Recent Developments
- 12.19 MRM Proteomics
- 12.19.1 MRM Proteomics Company Information
- 12.19.2 MRM Proteomics Business Overview
- 12.19.3 MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.19.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.19.5 MRM Proteomics Recent Developments
- 12.20 Lc-Bio Technologies
- 12.20.1 Lc-Bio Technologies Company Information
- 12.20.2 Lc-Bio Technologies Business Overview
- 12.20.3 Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.20.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.20.5 Lc-Bio Technologies Recent Developments
- 12.21 Eurofins Scientific
- 12.21.1 Eurofins Scientific Company Information
- 12.21.2 Eurofins Scientific Business Overview
- 12.21.3 Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.21.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.21.5 Eurofins Scientific Recent Developments
- 12.22 MtoZ-Biolabs
- 12.22.1 MtoZ-Biolabs Company Information
- 12.22.2 MtoZ-Biolabs Business Overview
- 12.22.3 MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.22.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.22.5 MtoZ-Biolabs Recent Developments
- 12.23 Creative Proteomics
- 12.23.1 Creative Proteomics Company Information
- 12.23.2 Creative Proteomics Business Overview
- 12.23.3 Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.23.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.23.5 Creative Proteomics Recent Developments
- 12.24 Macrogen
- 12.24.1 Macrogen Company Information
- 12.24.2 Macrogen Business Overview
- 12.24.3 Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.24.4 Macrogen Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.24.5 Macrogen Recent Developments
- 12.25 TATAA Biocenter
- 12.25.1 TATAA Biocenter Company Information
- 12.25.2 TATAA Biocenter Business Overview
- 12.25.3 TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.25.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.25.5 TATAA Biocenter Recent Developments
- 12.26 OmicScouts (Momentum Biotechnologies)
- 12.26.1 OmicScouts (Momentum Biotechnologies) Company Information
- 12.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 12.26.3 OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.26.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 12.27 Precision Biomarker Laboratories (PBL)
- 12.27.1 Precision Biomarker Laboratories (PBL) Company Information
- 12.27.2 Precision Biomarker Laboratories (PBL) Business Overview
- 12.27.3 Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.27.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 12.28 Shanghai OE Biotech
- 12.28.1 Shanghai OE Biotech Company Information
- 12.28.2 Shanghai OE Biotech Business Overview
- 12.28.3 Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.28.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.28.5 Shanghai OE Biotech Recent Developments
- 12.29 RxCelerate
- 12.29.1 RxCelerate Company Information
- 12.29.2 RxCelerate Business Overview
- 12.29.3 RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.29.4 RxCelerate Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.29.5 RxCelerate Recent Developments
- 12.30 Proteomics International
- 12.30.1 Proteomics International Company Information
- 12.30.2 Proteomics International Business Overview
- 12.30.3 Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.30.4 Proteomics International Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.30.5 Proteomics International Recent Developments
- 12.31 Proteome Sciences
- 12.31.1 Proteome Sciences Company Information
- 12.31.2 Proteome Sciences Business Overview
- 12.31.3 Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.31.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.31.5 Proteome Sciences Recent Developments
- 12.32 Westlake Omics
- 12.32.1 Westlake Omics Company Information
- 12.32.2 Westlake Omics Business Overview
- 12.32.3 Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.32.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.32.5 Westlake Omics Recent Developments
- 12.33 Crown Bioscience
- 12.33.1 Crown Bioscience Company Information
- 12.33.2 Crown Bioscience Business Overview
- 12.33.3 Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.33.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.33.5 Crown Bioscience Recent Developments
- 12.34 VProteomics
- 12.34.1 VProteomics Company Information
- 12.34.2 VProteomics Business Overview
- 12.34.3 VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.34.4 VProteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.34.5 VProteomics Recent Developments
- 12.35 Shanghai Majorbio Bio-Pharm
- 12.35.1 Shanghai Majorbio Bio-Pharm Company Information
- 12.35.2 Shanghai Majorbio Bio-Pharm Business Overview
- 12.35.3 Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.35.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 12.36 Applied Biomics
- 12.36.1 Applied Biomics Company Information
- 12.36.2 Applied Biomics Business Overview
- 12.36.3 Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.36.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.36.5 Applied Biomics Recent Developments
- 12.37 Sapient Bioanalytics
- 12.37.1 Sapient Bioanalytics Company Information
- 12.37.2 Sapient Bioanalytics Business Overview
- 12.37.3 Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.37.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.37.5 Sapient Bioanalytics Recent Developments
- 12.38 Allumiqs
- 12.38.1 Allumiqs Company Information
- 12.38.2 Allumiqs Business Overview
- 12.38.3 Allumiqs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.38.4 Allumiqs Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.38.5 Allumiqs Recent Developments
- 12.39 MS Bioworks
- 12.39.1 MS Bioworks Company Information
- 12.39.2 MS Bioworks Business Overview
- 12.39.3 MS Bioworks Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.39.4 MS Bioworks Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.39.5 MS Bioworks Recent Developments
- 12.40 Shanghai Bioprofile
- 12.40.1 Shanghai Bioprofile Company Information
- 12.40.2 Shanghai Bioprofile Business Overview
- 12.40.3 Shanghai Bioprofile Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.40.4 Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.40.5 Shanghai Bioprofile Recent Developments
- 12.41 Cosmos Wisdom
- 12.41.1 Cosmos Wisdom Company Information
- 12.41.2 Cosmos Wisdom Business Overview
- 12.41.3 Cosmos Wisdom Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.41.4 Cosmos Wisdom Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.41.5 Cosmos Wisdom Recent Developments
- 12.42 Olink (Thermo Fisher Scientific)
- 12.42.1 Olink (Thermo Fisher Scientific) Company Information
- 12.42.2 Olink (Thermo Fisher Scientific) Business Overview
- 12.42.3 Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.42.4 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.42.5 Olink (Thermo Fisher Scientific) Recent Developments
- 12.43 SomaLogic (Illumina)
- 12.43.1 SomaLogic (Illumina) Company Information
- 12.43.2 SomaLogic (Illumina) Business Overview
- 12.43.3 SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.43.4 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.43.5 SomaLogic (Illumina) Recent Developments
- 12.44 Labcorp
- 12.44.1 Labcorp Company Information
- 12.44.2 Labcorp Business Overview
- 12.44.3 Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)
- 12.44.4 Labcorp Plasma and Serum Proteomics Analysis Service Product Portfolio
- 12.44.5 Labcorp Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst